AI-generated summary
The authors report a split-body randomized trial of an 810-nm diode laser for keratosis pilaris in 18 completers with Fitzpatrick skin types I to III. Blinded raters found less roughness and bumpiness on treated sides than control sides after three treatments, but no significant improvement in redness. The abstract notes the small sample and that erythema may need additional treatment.
- Participants
- 18
- Who or what was studied
- Adults with keratosis pilaris on both arms, Fitzpatrick skin types I through III, at a dermatology outpatient practice
- Wavelengths
- 810 nm
- Limits stated in the abstract
- Small sample size, with 5 of 23 enrolled patients not completing follow-up or withdrawing, and a single center.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on archderm.jamanetwork.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength, Placebo-controlled, Trial registration, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.